|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Pediatric and Adolescent Osteosarcoma. Springer;
New York, NY: pp. 3–13. 2009, View Article : Google Scholar
|
|
2
|
Laux CJ, Berzaczy G, Weber M, Lang S,
Dominkus M, Windhager R, Nöbauer-Huhmann IM and Funovics PT: Tumour
response of osteosarcoma to neoadjuvant chemotherapy evaluated by
magnetic resonance imaging as prognostic factor for outcome. Int
Orthop. 39:97–104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment - where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gregory RI and Shiekhattar R: MicroRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartels CL and Tsongalis GJ: MicroRNAs:
Novel biomarkers for human cancer. Clin Chem. 55:623–631. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. MicroRNA Cancer Regulation. Springer;
pp. 1–20. 2013, View Article : Google Scholar
|
|
9
|
Shen J, Stass SA and Jiang F: MicroRNAs as
potential biomarkers in human solid tumors. Cancer Lett.
329:125–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miao J, Wu S, Peng Z, Tania M and Zhang C:
MicroRNAs in osteosarcoma: Diagnostic and therapeutic aspects.
Tumour Biol. 34:2093–2098. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Motoyama K, Inoue H, Takatsuno Y, Tanaka
F, Mimori K, Uetake H, Sugihara K and Mori M: Over- and
under-expressed microRNAs in human colorectal cancer. Int J Oncol.
34:1069–1075. 2009.PubMed/NCBI
|
|
14
|
Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng
X and Tu K: MicroRNA-92a contributes to tumor growth of human
hepatocellular carcinoma by targeting FBXW7. Oncol Rep.
34:2576–2584. 2015.PubMed/NCBI
|
|
15
|
Zhang H, Cao H, Xu D and Zhu K:
MicroRNA-92a promotes metastasis of nasopharyngeal carcinoma by
targeting the PTEN/AKT pathway. Onco Targets Ther. 9:3579–3588.
2016.PubMed/NCBI
|
|
16
|
Gougelet A, Pissaloux D, Besse A, Perez J,
Duc A, Dutour A, Blay JY and Alberti L: Micro-RNA profiles in
osteosarcoma as a predictive tool for ifosfamide response. Int J
Cancer. 129:680–690. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Namløs HM, Meza-Zepeda LA, Barøy T,
Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H,
Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma
expression phenotype by microRNAs. PLoS One. 7:e480862012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiong J, Li Z, Zhang Y, Li D, Zhang G, Luo
X, Jie Z, Liu Y, Cao Y, Le Z, et al: PRL-3 promotes the peritoneal
metastasis of gastric cancer through the PI3K/Akt signaling pathway
by regulating PTEN. Oncol Rep. 36:1819–1828. 2016.PubMed/NCBI
|
|
19
|
Xie Y, Naizabekov S, Chen Z and Tokay T:
Power of PTEN/AKT: Molecular switch between tumor suppressors and
oncogenes. Oncol Lett. 12:375–378. 2016.PubMed/NCBI
|
|
20
|
Zhou T, Zhang G, Liu Z, Xia S and Tian H:
Overexpression of miR-92a correlates with tumor metastasis and poor
prognosis in patients with colorectal cancer. Int J Colorectal Dis.
28:19–24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pelossof R, Chow OS, Fairchild L, Smith
JJ, Setty M, Chen CT, Chen Z, Egawa F, Avila K, Leslie CS, et al:
Integrated genomic profiling identifies microRNA-92a regulation of
IQGAP2 in locally advanced rectal cancer. Genes Chromosomes Cancer.
55:311–321. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Q, Yang Z, Wang F, Hu S, Yang L, Shi Y
and Fan D: MiR-19b/20a/92a regulates the self-renewal and
proliferation of gastric cancer stem cells. J Cell Sci.
126:4220–4229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao J, Fu W, Liao H, Dai L, Jiang Z, Pan
Y, Huang H, Mo Y, Li S, Yang G, et al: The regulatory and
predictive functions of miR-17 and miR-92 families on cisplatin
resistance of non-small cell lung cancer. BMC Cancer. 15:7312015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou C, Shen L, Mao L, Wang B, Li Y and Yu
H: miR-92a is upregulated in cervical cancer and promotes cell
proliferation and invasion by targeting FBXW7. Biochem Biophys Res
Commun. 458:63–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ohyagi-Hara C, Sawada K, Kamiura S, Tomita
Y, Isobe A, Hashimoto K, Kinose Y, Mabuchi S, Hisamatsu T,
Takahashi T, et al: miR-92a inhibits peritoneal dissemination of
ovarian cancer cells by inhibiting integrin α5 expression. Am J
Pathol. 182:1876–1889. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ortega-Molina A and Serrano M: PTEN in
cancer, metabolism, and aging. Trends Endocrinol Metab. 24:184–189.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song MS, Salmena L and Pandolfi PP: The
functions and regulation of the PTEN tumour suppressor. Nat Rev Mol
Cell Biol. 13:283–296. 2012.PubMed/NCBI
|
|
28
|
Karreth FA, Tay Y, Perna D, Ala U, Tan SM,
Rust AG, DeNicola G, Webster KA, Weiss D, Perez-Mancera PA, et al:
In vivo identification of tumor- suppressive PTEN ceRNAs in an
oncogenic BRAF-induced mouse model of melanoma. Cell. 147:382–395.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li M, Chen H, Zhao Y, Gao S and Cheng C:
H19 Functions as a ceRNA in promoting metastasis through decreasing
miR-200s activity in osteosarcoma. DNA Cell Biol. 35:235–240. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen J, Yan D, Wu W, Zhu J, Ye W and Shu
Q: MicroRNA-130a promotes the metastasis and epithelial-mesenchymal
transition of osteosarcoma by targeting PTEN. Oncol Rep.
35:3285–3292. 2016.PubMed/NCBI
|
